Cerus - CERS Net Assets per Single Share

Graphic logo of Cerus Corp. (CERS)

The daily price chart for Cerus Corporation (CERS) illustrates the asset's performance, with its metric currently at 0.35. Cerus Corporation leads in ensuring the uninterrupted supply of transfusion reagents, leveraging a global network of hubs to protect margins. Revenues are based on the sale of consumables for installed blood filtration systems. The current growth trajectory relies on expansion in Europe and the US alongside the launch of new products.

Cerus Corp. (CERS) - Accounting Value per Share from 07/04/2022 to 10/28/2026

Summary analytical data breakdowns for cerus.com (CERS)

- price and consensus price forecast:
Price Chart Cerus Corp|CERS - Fair Value Consensus
- market capitalization data:
Market Value Cerus Corporation|CERS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Cerus|CERS - Company Net Assets|Market Capitalization to Book Value Ratio cerus.com|CERS - Company Assets
- debt and liquidity data:
Total Debt to Capital Cerus Corporation|CERS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Cerus|CERS - Company Total Debt Obligations|Debts to Book Capitalization Cerus Corporation|CERS - Company Long-Term Liabilities|Company Short-Term Debts Cerus
Analysis of all company metrics:Cerus Corp - CERS
Manufactured product of cerus.com

Cerus Corporation (CERS) maintains pricing power within the blood safety sector, ensuring a steady capital inflow that is reflected in the positive trend of the book value per share metric. This indicator is calculated as the ratio of net assets to the number of common shares, allowing investors to assess the real value of a single ownership stake in the business and the stability of its resource base.

Competitors of Cerus Corporation (CERS)

Net Assets per Single Share Intuitive Surgical Inc (ISRG)|DHR: Accounting Value of a Share|Becton Dickinson & Co - Net Assets per Single Share|STE (steris.com) - Net Assets per Share|Net Assets per Single Share WST|Accounting Value per Share Baxter International Inc.|Masimo Personal Health - Book Value per Share|Net Asset Value per Share Stevanato Group Corp (STVN)|TFX - Book Value per Share|Equity per Share merit.com MMSI|Book Value per Share NVST (Envista)|ICUI - Net Assets per Share|XRAY (Dentsply) - Book Value per Share|LeMaitre Corp (LMAT) - Accounting Value per Share|ATRC (AtriCure, Inc.) - Book Value per Share|Book Value per Share STAA|Net Assets per Single Share ChromaDex Corporation (NAGE)|Net Assets per Single Share ZimVie Inc ZIMV|Accounting Value per Share AngioDynamics Corp|Accounting Value of a Share Teknova Inc TKNO|Book Value per Share MGRM (Monogram Technologies)|STSS: Net Assets per Share|Net Assets per Single Share infusystem.com|UTMD (Utah Medical Products Inc.) - Equity per Share|KRMD: Net Assets per Single Share|Net Assets per Share Nyxoah S.A (NYXH)|Accounting Value per Share Microbot Medical Inc.|Book Price of a Share PDEX (pro-dex.com)|Net Assets per Single Share Zentek|ELUT - Accounting Value of a Share|Milestone Scientific Corp - Accounting Value per Share|NXGL: Book Value per Share|RVP (retractable.com) - Net Assets per Single Share|harvardbioscience.com (HBIO) - Accounting Value per Share|Book Value per Share FEMY (Femasys)|Net Asset Value per Share MHUA|Net Assets per Single Share Predictive Oncology POAI|Equity per Share callanjmb.com CJMB|Accounting Value per Share Atrion Corporation (ATRI)|neurometrix.com - Book Price of a Share